Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 4/20 | 0.44 |
| ▸ | AVPR1B | P47901 | 2/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.43 |
| ▸ | AVPR2 | P30518 | 8/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.38 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7018912 | 0.99 | AVPR1A (0.44) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7017226 | 0.92 | AVPR1A (0.45) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7019987 | 0.87 | PDE4A (0.53) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7019167 | 0.87 | AVPR2 (0.42) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| Hydrochloric Acid SCHEMBL7024085 | 0.86 | AVPR2 (0.42) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7018124 | 0.86 | RPS6KA3 (0.42) | AVPR1AAVPR1BAVPR2LMNAPDCD1 | |
| SCHEMBL7017240 | 0.84 | PDE4A (0.50) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7022859 | 0.84 | BRD4 (0.47) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7015488 | 0.84 | AVPR1A (0.50) | AVPR1AAVPR1BPDE4APDE4BPDE4C | |
| SCHEMBL7020818 | 0.84 | MAPT (0.43) | AVPR1AAVPR1BPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051415-B1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-6495542-B1 | SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-1051415-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999037637-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-07-29 | — | — | WO | disclosed |